Pnc Financial Services Group, Inc. Aldeyra Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 94 shares of ALDX stock, worth $242. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94
Previous 34
176.47%
Holding current value
$242
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ALDX
# of Institutions
139Shares Held
38.6MCall Options Held
620KPut Options Held
435K-
Perceptive Advisors LLC New York, NY9.28MShares$23.9 Million2.23% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$14.1 Million21.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.72MShares$9.59 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$9.34 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT1.75MShares$4.52 Million2.26% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $150M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...